but without the active substance clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy
This study looks at a spray treatment for birch pollen allergy. It wants to see if this spray, used under the tongue, can reduce symptoms like sneezing and itchy eyes, and if it's safe to use, compared to a dummy spray.
For: Moderate-to-severe allergic rhinitis / rhinoconjunctivitis due to birch pollen for at least two years according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelineGermany - Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy
This study is looking at a new way to treat grass pollen allergy using a spray under the tongue. It wants to see if this `sublingual immunotherapy` can reduce hay fever symptoms and the need for other medicines, making life better for people with moderate to severe grass pollen allergies.
For: Moderate-to-severe allergic rhinitis / rhinoconjunctivitis due to grass pollen for at least two years according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelineGermany - Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from Olea europaea pollen allergy
This study is testing a new treatment for olive pollen allergy. It's looking at how well different doses of an injection, called CLU-RX-OLE, can reduce allergy symptoms like sneezing and runny nose, and if it's safe to use.
For: Moderate-to-severe allergic rhinitis / rhinoconjunctivitis due to olive pollen for at least two years according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelineSpain - AuthorisedPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy
This study is looking for better ways to treat birch pollen allergy. It tests different doses of a new medicine, given under the tongue, to see if it can reduce symptoms like sneezing and itchy eyes during pollen season.
Germany - Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of subcutaneous cluster-immunotherapy in patients suffering from house dust mite allergy
This study is testing a new injection treatment for house dust mite allergy. It aims to see if different doses of the treatment can reduce hay fever-like symptoms like sneezing and runny nose, and if it's safe to use, compared to a dummy injection.
For: Moderate-to-severe allergic rhinitis / rhino-conjunctivitis due to house dust mites (HDM) for at least one year according to the "Allergic Rhinitis and its Impact on Asthma" (ARIA · Bousquet et al.Spain · Germany